29
Jan
2020
How biosimilar priced in US market?
Unlike generics, biosimilars are not highly discounted to it’s patented molecule. Biosimilars are in average around 15-20% lesser price tag... Read More
Sign In
|Sign Up
Please sign in first
Not a member?
Please simply create an account before buying/booking any courses.
Create an account for free!
Recently Published Articles
29
Jan
2020
Pfizer launched Zirabev, Ruxience, Trazimera biosimilar in US
Pfizer has launched three biosimilars in the U.S. market. Pfizer has priced these biosimilars aggressively to get quick market share.... Read More
29
Jan
2020
Merck’s Dificid received USFDA approval for Infections in Children
The USFDA has approved Merck’s Dificid drug for children aged 6 months and older who have diarrhea caused by a... Read More
29
Jan
2020
EyePoint Pharmaceuticals and Ocumension Therapeutics’s Exclusive License Agreement to Develop and Commercialize DEXYCU
EyePoint Pharmaceuticals Inc., a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and Ocumension Therapeutics, a fast-growing ophthalmology... Read More
29
Jan
2020
Helsinn out-licenses Akynzeo and Onicit in Russia to Berlin-Chemie
Helsinn out-licenses Akynzeo (netupitant/palonosetron) and Onicit (palonosetron) for Russia and the CIS region to Berlin-Chemie, the German-based affiliate of Italy’s... Read More
20
Jan
2020
Insight on 2019 USFDA New Drug Approval
Here is a analytics showing USFDA new drug approval year by year. >> Click here to view
20
Jan
2020
Insight on J&J’s TB mass awareness campaign in India
Johnson & Johnson Services has recently taken a TB awareness initiative in India, collaboration with MTV Staying Alive Foundation. The... Read More
20
Jan
2020
CUTX-101 of Fortress Biotech gets US FDA rare pediatric disease designation to treat Menkes disease
Fortress Biotech, an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates,... Read More
20
Jan
2020
What is Edible security tag?
The edible security tag, a thin, transparent film made of silk proteins and fluorescent proteins genetically fused together utilizes an... Read More
28
Dec
2019
Acquisition in Pharma: Why Astellas to acquire Xyphos Biosciences?
Astellas Pharma Inc. has agreed to acquire Xyphos Biosciences, Inc. Why Astellas acquired Xyphos? With the acquisition Astellas will gain... Read More
25
Dec
2019
US FDA issued CRL to ViiV Healthcare for use of cabotegravir and rilpivirine long-acting regimen for treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, received... Read More
25
Dec
2019
US FDA issues Complete Response Lette to Takeda’s Entyvio for maintenance therapy in adults with ulcerative colitis
Takeda Pharmaceutical Company Limited received a Complete Response Letter from the US Food and Drug Administration (FDA) in response to... Read More
25
Dec
2019
What is ISO 15197:2013 certification?
ISO 15197:2013 specifies requirements for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples, for specific design verification... Read More
25
Dec
2019
Copromotion deal for Japan – Gilead and Eisai in RA therapy filgotinib
Gilead Sciences, Inc and Eisai Co, Ltd announced that Gilead Sciences K.K and Eisai have entered into an agreement for... Read More
25
Dec
2019
Insight on USFDA approval of Allergan’s Ubrelvy
Allergan plc announced that the US Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy... Read More
5
Dec
2019
Insight on Alteogen’s non-exclusive licensing deal for ALT-B4 to a top 10 global pharma
South Korean company Alteogen Inc. signed a nonexclusive global license agreement with a top 10 global pharmaceutical company for its... Read More
5
Dec
2019
Pharma Strategic Deal: Astellas Pharma to acquire Audentes Therapeutics for about $3 billion
Astellas Pharma Inc. anannounced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price... Read More
4
Dec
2019
Pharma Business Development – Competency Test. Check your competency
Pharma Business Development – Competency Test. Check your competency
2
Dec
2019
Case study: Novartis to acquire The Medicines Company for $9.7 billion, get hold of inclisiran, a cholesterol drug
Novartis, a one of the leading global pharmaceutical company, to acquire The Medicines Company for $9.7 billion. Strategic reasoning of... Read More
19
Nov
2019
What is USFDA Purple Book? What it’s significance?
The “Purple Book” lists biological products, including any biosimilar and interchangeable biological products, licensed by FDA under the Public Health... Read More
19
Nov
2019
USFDA approved Pfizer’s Abrilada, a biosimilar of Humira
The U.S. Food and Drug Administration (FDA) approved Pfizer’s Abrilada, a biosimilar of Humira. Pfizer said the FDA approved Abrilada (adalimumab-afzb) for the... Read More
17
Nov
2019
Pfizer’s Upjohn and Mylan merged business entity will be namea as Viatris
The name of the new company to be formed by the merger of Mylan and Upjohn, a division of Pfizer,... Read More
17
Nov
2019
Bayer and Dewpoint Therapeutics co-development deal for cardiovascular and gynecological diseases
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and... Read More
17
Nov
2019
Sandoz to Acquire Japanese Biz of AGI
Sandoz has entered into an agreement to acquire the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary... Read More
17
Nov
2019
Selumetinib NDA Submission for Neurofibromatosis Type 1 (NF1) granted Priority Review
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and... Read More
17
Nov
2019
Insignt on Roche’s Up-to-$1.4Billion Promedior Acquisition
Roche has agreed to acquire Promedior for up to $1.4 billion. Roche’s deal will give it full rights to Promedior’s... Read More
1
Nov
2019
Case Study: 505(b)(2) filing pathway – USFDA approval of Vumerity
Biogen, global biotechnology company, and Alkermes, global biopharmaceutical company, announced that the US Food and Drug Administration (FDA) approved Vumerity... Read More
1
Nov
2019
US FDA places partial hold on Novartis’ AVXS-101 intrathecal study
USFDA placed a partial hold on clinical trials for intrathecal administration of AVXS-101. The announcement follows an AveXis communication to... Read More
29
Oct
2019
Zentiva to acquire CEE pharma business of Alvogen
Czech drugmaker Zentiva has announced it will buy the Central and Eastern European business of Alvogen, for an undisclosed amount.... Read More
29
Oct
2019
Insighht on USFDA approval of Trikafta
Vertex Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA). This is a landmark approval where Vertex’s Trikafta... Read More